Insulinoma-Associated Protein 1 (INSM1) Immunohistochemistry is A Useful Diagnostic Marker for the Evaluation of Primary Thymic Neuroendocrine Neoplasms

被引:0
|
作者
Chacko, Davis [1 ]
Hung, Yin [2 ]
Mino-Kenudson, Mari [3 ]
VanderLaan, Paul [4 ]
Suster, David [5 ]
机构
[1] Rutgers New Jersey Med Sch, Univ Hosp, Newark, NJ USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
[5] Rutgers State Univ, Rutgers New Jersey Med Sch, Newark, NJ USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1522
引用
收藏
页码:S1900 / S1901
页数:2
相关论文
共 50 条
  • [1] Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor
    Masahiko Tanigawa
    Masamichi Nakayama
    Tomoki Taira
    Satoshi Hattori
    Yutaro Mihara
    Reiichiro Kondo
    Hironori Kusano
    Ken Nakamura
    Yushi Abe
    Yusuke Ishida
    Yoshinobu Okabe
    Toru Hisaka
    Koji Okuda
    Kosuke Fujino
    Takaaki Ito
    Akihiko Kawahara
    Yoshiki Naito
    Rin Yamaguchi
    Jun Akiba
    Yoshito Akagi
    Hirohisa Yano
    Medical Molecular Morphology, 2018, 51 : 32 - 40
  • [2] Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor
    Tanigawa, Masahiko
    Nakayama, Masamichi
    Taira, Tomoki
    Hattori, Satoshi
    Mihara, Yutaro
    Kondo, Reiichiro
    Kusano, Hironori
    Nakamura, Ken
    Abe, Yushi
    Ishida, Yusuke
    Okabe, Yoshinobu
    Hisaka, Toru
    Okuda, Koji
    Fujino, Kosuke
    Ito, Takaaki
    Kawahara, Akihiko
    Naito, Yoshiki
    Yamaguchi, Rin
    Akiba, Jun
    Akagi, Yoshito
    Yano, Hirohisa
    MEDICAL MOLECULAR MORPHOLOGY, 2018, 51 (01) : 32 - 40
  • [3] Insulinoma-associated protein-1 (INSM-1) is a useful diagnostic marker for the evaluation of primary thymic neuroendocrine neoplasms: an immunohistochemical study of 27 cases
    Suster, David
    Chacko, Davis
    VanderLaan, Paul
    Mino-Kenudson, Mari
    Hung, Yin P.
    VIRCHOWS ARCHIV, 2024,
  • [4] Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix
    Kuji, Shiho
    Endo, Akira
    Kubota, Manabu
    Uekawa, Atsushi
    Kawakami, Fumi
    Mikami, Yoshiki
    Koike, Junki
    Suzuki, Nao
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2023, 34 (01)
  • [5] Insulinoma- Associated Protein 1 ( INSM1) Expression in Neuroendocrine Neoplasms: A Newly Discovered Diagnostic Marker
    Vanik, Sangita A.
    Jetly, Dhaval
    Dhandapani, Karthik
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2024, 45 (04) : 306 - 311
  • [6] Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors
    Kim, David
    Viswanathan, Kartik
    Goyal, Abha
    Rao, Rema
    CANCER CYTOPATHOLOGY, 2020, 128 (04) : 269 - 277
  • [7] Insulinoma-associated protein 1 (INSM1) is a sensitive and specific marker of neuroendocrine neoplasia in the gastrointestinal tract
    Lee, Hee Eun
    Wu, Tsung-Teh
    Said, Samar
    Zhang, Lizhi
    Bellizzi, Andrew
    Graham, Rondell
    LABORATORY INVESTIGATION, 2019, 99
  • [8] Insulinoma-associated protein 1 (INSM1) is a sensitive and specific marker of neuroendocrine neoplasia in the gastrointestinal tract
    Lee, Hee Eun
    Wu, Tsung-Teh
    Said, Samar
    Zhang, Lizhi
    Bellizzi, Andrew
    Graham, Rondell
    MODERN PATHOLOGY, 2019, 32
  • [9] Comparison of Diagnostic Utility of Delta-Like Ligand 3 to Insulinoma-Associated protein 1 (INSM1) in Neuroendocrine Neoplasms of Lung
    Danakas, Alexandra
    Velez, Moises
    Syposs, Chauncey
    Cheris, Sachica
    Agrawal, Tanupriya
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1099 - 1101
  • [10] Comparison of Diagnostic Utility of Delta-Like Ligand 3 to Insulinoma-Associated protein 1 (INSM1) in Neuroendocrine Neoplasms of Lung
    Danakas, Alexandra
    Velez, Moises
    Syposs, Chauncey
    Cheris, Sachica
    Agrawal, Tanupriya
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1099 - 1101